X-115189683-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The ENST00000317135.13(LRCH2):c.350-1313A>C variant causes a intron change. The variant allele was found at a frequency of 0.000006 in 1,167,196 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000088 ( 0 hom., 0 hem., cov: 25)
Exomes 𝑓: 0.0000057 ( 0 hom. 2 hem. )
Consequence
LRCH2
ENST00000317135.13 intron
ENST00000317135.13 intron
Scores
8
4
5
Clinical Significance
Conservation
PhyloP100: 3.71
Genes affected
RBMXL3 (HGNC:26859): (RBMX like 3) Predicted to enable mRNA binding activity and snRNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be part of U12-type spliceosomal complex. [provided by Alliance of Genome Resources, Apr 2022]
LRCH2 (HGNC:29292): (leucine rich repeats and calponin homology domain containing 2) This gene encodes a member of the leucine-rich repeat and calponin homology domain-containing protein family. These family members contain multiple N-terminal leucine-rich repeats, in addition to a C-terminal calponin homology domain, a type of domain that mediates interactions with actin filaments. These proteins are conserved across animal species, and studies of a similar Drosophila protein indicate a function as a cytoskeletal scaffolding protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.87
BS2
High Hemizygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBMXL3 | NM_001145346.2 | c.242T>G | p.Val81Gly | missense_variant | 1/1 | ENST00000424776.5 | NP_001138818.1 | |
LRCH2 | NM_020871.4 | c.350-1313A>C | intron_variant | ENST00000317135.13 | NP_065922.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBMXL3 | ENST00000424776.5 | c.242T>G | p.Val81Gly | missense_variant | 1/1 | NM_001145346.2 | ENSP00000417451 | P1 | ||
LRCH2 | ENST00000317135.13 | c.350-1313A>C | intron_variant | 1 | NM_020871.4 | ENSP00000325091 | P2 | |||
LRCH2 | ENST00000538422.2 | c.350-1313A>C | intron_variant | 1 | ENSP00000439366 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000884 AC: 1AN: 113173Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 35313
GnomAD3 genomes
AF:
AC:
1
AN:
113173
Hom.:
Cov.:
25
AF XY:
AC XY:
0
AN XY:
35313
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000569 AC: 6AN: 1054023Hom.: 0 Cov.: 33 AF XY: 0.00000580 AC XY: 2AN XY: 344905
GnomAD4 exome
AF:
AC:
6
AN:
1054023
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
344905
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000884 AC: 1AN: 113173Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 35313
GnomAD4 genome
AF:
AC:
1
AN:
113173
Hom.:
Cov.:
25
AF XY:
AC XY:
0
AN XY:
35313
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | The c.242T>G (p.V81G) alteration is located in exon 1 (coding exon 1) of the RBMXL3 gene. This alteration results from a T to G substitution at nucleotide position 242, causing the valine (V) at amino acid position 81 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Loss of stability (P = 0.0189);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at